| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |